TheraNyM Biologics opens ₹1,200 crore manufacturing facility near Hyderabad
TheraNyM Biologics, a subsidiary of Aurobindo Pharma, has inaugurated a ₹1,200 crore manufacturing facility near Hyderabad to produce drugs for cancer and other diseases. The project is expected to create over 1,500 jobs and strengthen Telangana's position in the global life sciences sector.
Why it matters
This investment underscores the growth of India's pharmaceutical manufacturing capacity and its role in the global supply chain for biological medicines.
A ₹1,200 crore manufacturing facility of generic drugmaker Aurobindo Pharma’s subsidiary TheraNyM Biologics near Hyderabad, with a potential to generate more than 1,500 jobs for the local youth, was opened on Wednesday (June 3, 2026).
The article reports on business expansion and economic development using official government and corporate statements.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in